Cocrystal Pharma, Inc. COCP
Set alert
At close · Oct 30
After hours · Oct 30, 4:06 PM ET
- YTD
- +1.53%
- 1 year
- -8.72%
- Open
- 0.95
- Prev close
- 0.98
- Mkt cap
- 19.17M
- Vol
- 62.76K
- Avg vol
- 58.02K
- EPS
- -0.76
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.95
- High
- 1.01
- Forward P/E
- -1.22
- Beta
- 1.45
- Short ratio
- 0.12
- Inst. own
- 6.94%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 1.96
- 200-d avg
- 1.91
- 1y target
- 8.00
5D chart
Signals (71)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 12:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 11:55 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:45 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:15 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:10 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:00 AM | 2 days ago |
| RSI: Overbought | Oct 30, 10:40 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:05 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:50 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:50 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:30 PM | 3 days ago |
| RSI: Overbought | Oct 29, 2:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:20 PM | 3 days ago |
| RSI: Oversold | Oct 29, 2:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:00 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:00 PM | 3 days ago |
| RSI: Oversold | Oct 29, 1:00 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:40 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:00 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:00 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:00 AM | 3 days ago |
| RSI: Oversold | Oct 29, 11:00 AM | 3 days ago |
| RSI: Overbought | Oct 28, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:40 PM | 4 days ago |
| RSI: Overbought | Oct 28, 12:40 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 10:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:30 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:45 PM | 5 days ago |
| RSI: Overbought | Oct 27, 12:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:35 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 11:20 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:20 AM | 5 days ago |
| RSI: Overbought | Oct 27, 11:20 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:35 AM | 5 days ago |
| RSI: Oversold | Oct 27, 10:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:20 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:15 AM | 5 days ago |
| RSI: Oversold | Oct 26, 3:55 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:15 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:00 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:55 PM | 6 days ago |
| RSI: Oversold | Oct 26, 12:55 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:40 PM | 6 days ago |
| RSI: Oversold | Oct 26, 11:55 AM | 6 days ago |
News
1 month ago globenewswire.com
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
No serious adverse events reported to date Preliminary efficacy results expected in late 2026 or early 2027 MIAMI, Fla. And BOTHELL, Wash.
2 months ago globenewswire.com
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
BOTHELL, Wash., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) ("Cocrystal" or the "Company"), a clinical-stage biotechnology company developing novel therapeutics to meet…
-
2 months ago benzinga.com
Cocrystal Pharma Q2 EPS $(0.23) Misses $(0.17) Estimate, Sales $105.000K
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.17) by 43.75 percent. This is a 15 percent decrease over losses of…
-
3 months ago benzinga.com
Cocrystal Pharma Secures $5M Investment From OPKO Health To Advance Norovirus Program Toward Phase 1b Data
Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b data in late 2026BOTHELL, Wash., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc.…
3 months ago globenewswire.com
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b data in late 2026 BOTHELL, Wash., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc.…
3 months ago defenseworld.net
Financial Contrast: Cocrystal Pharma (NASDAQ:COCP) vs. Zevra Therapeutics (NASDAQ:ZVRA)
Zevra Therapeutics (NASDAQ: ZVRA - Get Free Report) and Cocrystal Pharma (NASDAQ: COCP - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will…
5 months ago globenewswire.com
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
BOTHELL, Wash. , June 03, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma Inc. (Nasdaq: COCP) ("Cocrystal" or the "Company"), a clinical-stage biotechnology company developing novel therapeutics to meet…
-
5 months ago benzinga.com
Watching Cocrystal Pharma; Zacks-Small Cap Research Gives Stock $8 Price Valuation
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_06012026_COCP_Bautz.pdf
-
5 months ago benzinga.com
Cocrystal Pharma's Direct-Acting Antivirals Demonstrate Pan-Viral Activity Against Multiple Viruses, Including Hantavirus, Bunyavirus And Influenza
Novel, potent pan-viral inhibitors targeting the viral replication complex are under development for the treatment of hantavirus, bunyavirus and influenzaHantavirus and bunyavirus infections…
5 months ago globenewswire.com
Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
Novel, potent pan-viral inhibitors targeting the viral replication complex are under development for the treatment of hantavirus, bunyavirus and influenza Hantavirus and bunyavirus infections…
-
5 months ago benzinga.com
Cocrystal Pharma Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $225.000K
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 26.09 percent increase over losses of…
5 months ago globenewswire.com
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
BOTHELL, Wash., May 15, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) provides updates on its antiviral product pipeline and business activities and…
-
6 months ago benzinga.com
Cocrystal Pharma Features Mechanism Of Action And Clinical Advancement Of Oral Protease Inhibitor CDI-988 In Oral Presentation At 39th ICAR 2026
Ongoing Phase 1b human challenge study with oral, direct-acting protease inhibitor is designed to demonstrate proof-of-concept as a preventive and a treatmentFully enrolled first cohort is assessing…
6 months ago globenewswire.com
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
BOTHELL, Wash., April 30, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that the mechanism of action and clinical advancement of its first…
-
6 months ago benzinga.com
Cocrystal Pharma Files $150M Shelf Offering To Sell Stock, Warrants, And Other Securities
$150,000,000 Cocrystal Pharma, Inc. Common StockPreferred StockWarrantsUnits Cocrystal Pharma, Inc. ("Cocrystal," the "Company," "we," "our," or "us") intends to offer and sell from time to time the
6 months ago benzinga.com
Why Cocrystal Pharma Shares Are Cooling Off Monday?
COCP stock is trading lower Monday morning. Learn why Cocrystal Pharma is seeing a pullback after receiving FDA Fast Track designation for CDI-988.
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
7 months ago benzinga.com
Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results
US stocks fall, Dow drops over 50 points, real estate shares rise, Acuity Inc. shares decline, Sky Quarry Inc. and Cocrystal Pharma Inc. shares increase.
7 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
7 months ago benzinga.com
Nasdaq Down 1%; US Initial Jobless Claims Fall
US stocks traded lower on Thursday, with the Nasdaq falling 1%. Energy shares rose, while consumer discretionary stocks fell. US jobless claims declined.
7 months ago benzinga.com
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988
The company said the FDA's Fast Track designation is intended to facilitate development and expedite regulatory review for drugs that treat serious conditions and address unmet medical needs.
7 months ago benzinga.com
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988
Cocrystal Pharma Inc. (NASDAQ:COCP) shares are trading higher Thursday after it received Fast Track designation from the FDA for its CDI-988.
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
7 months ago globenewswire.com
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
FDA Fast Track designation supports accelerated development and expedites regulatory review Norovirus is responsible for an estimated 685 million global cases each year and approximately $60 billion…
7 months ago globenewswire.com
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Phase 1b norovirus challenge study is underway at Emory University School of Medicine CDI-988 is the first oral antiviral candidate being developed for norovirus treatment and prevention No approved…
7 months ago defenseworld.net
Cocrystal Pharma (COCP) Expected to Announce Earnings on Monday
Cocrystal Pharma (NASDAQ: COCP - Get Free Report) is anticipated to issue its results before the market opens on Monday, March 30th. Analysts expect the company to announce earnings of ($0.18) per…
7 months ago defenseworld.net
Cocrystal Pharma (NASDAQ:COCP) Shares Up 2% – Should You Buy?
Cocrystal Pharma, Inc. (NASDAQ: COCP - Get Free Report)'s stock price traded up 2% during mid-day trading on Monday. The stock traded as high as $1.0338 and last traded at $1.03. 48,239 shares…
7 months ago globenewswire.com
First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment
CDI-988 is a direct-acting, oral antiviral being developed for norovirus Norovirus challenge study is underway at Emory University School of Medicine to evaluate efficacy and safety of CDI-988 No…
8 months ago globenewswire.com
Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
BOTHELL, Wash., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that initial progress of a norovirus challenge study with its…
10 months ago defenseworld.net
Insider Buying: Cocrystal Pharma (NASDAQ:COCP) Director Buys $19,400.00 in Stock
Cocrystal Pharma, Inc. (NASDAQ: COCP - Get Free Report) Director Phillip Md Et Al Frost bought 20,000 shares of Cocrystal Pharma stock in a transaction on Tuesday, December 30th. The stock was…
10 months ago globenewswire.com
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
BOTHELL, Wash., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces the approval from the Institutional Review Board (IRB) at Emory…
11 months ago globenewswire.com
Cocrystal Pharma to Present at the Noble Capital Markets' 21st Emerging Growth Equity Conference
BOTHELL, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a Company overview and…
11 months ago globenewswire.com
Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatment Expects to initiate CDI-988 Phase 1b norovirus challenge study in Q1 2026 Granted NIH SBIR award to advance…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
US Stocks Open Higher; House Prices Increase In October
US Stocks Open Higher; House Prices Increase In October
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
3 years ago benzinga.com
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 258 companies hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 325 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
OnFriday, 143 stocks hit new 52-week lows.
-
3 years ago benzinga.com
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
-
4 years ago benzinga.com
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 413 companies reached new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 446 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 838 companies hit new 52-week lows.